Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Genetics Institute, LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 2005, the institute has made significant strides in genetic research and personalised medicine, establishing itself as a pioneer in the field.
The company specialises in advanced genomic sequencing and analysis, offering unique services that cater to both clinical and research applications. Its innovative approach to genetic testing and data interpretation sets it apart from competitors, ensuring high accuracy and reliability.
With a strong market position, Genetics Institute, LLC has achieved notable milestones, including partnerships with renowned research institutions and contributions to groundbreaking studies in genomics. The institute continues to drive advancements in genetic technology, making a lasting impact on healthcare and scientific research.
+58 vs industry average
Genetics Institute, LLC’s score of 100 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Genetics Institute, LLC yet.
Genetics Institute, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Pfizer Inc., which means that any relevant emissions data or climate commitments may be inherited from its parent organisation.
As part of its corporate family relationship with Pfizer Inc., Genetics Institute, LLC aligns with the climate initiatives and targets set by Pfizer. This includes commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Pfizer Inc. at a first-level relationship. However, specific reduction targets or achievements for Genetics Institute, LLC have not been detailed.
While no direct emissions data is available, the overarching commitment to sustainability and climate action is evident through its affiliation with Pfizer, which actively engages in reducing its carbon footprint and addressing climate change.
No climate goals have been disclosed for Genetics Institute, LLC yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Genetics Institute, LLC yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more